The Future of Women’s Health Wearables and the First Continuous Hormone Monitor with Jenny Duan, CEO & Co-Founder of Clair Health
What if women finally had access to real-time hormone data instead of being told to “wait and see” or having their symptoms dismissed altogether?
In this episode of Reclaim, I sat down with Jenny Duan, co-founder of Clair, the company building what could become the world’s first continuous hormone monitor for women. We talked about the massive gaps in women’s healthcare, why existing wearables weren’t designed with women in mind, and how Clair is aiming to bridge the divide between personalized health data and actionable care.
What if women finally had access to real-time hormone data instead of being told to “wait and see” or having their symptoms dismissed altogether?
In this episode of Reclaim, I sat down with Jenny Duan, co-founder of Clair, the company building what could become the world’s first continuous hormone monitor for women. We talked about the massive gaps in women’s healthcare, why existing wearables weren’t designed with women in mind, and how Clair is aiming to bridge the divide between personalized health data and actionable care.
Jenny shared her journey from consumer tech and creator economy startups into women’s health innovation, why she believes hormones are the “operating system” of the female body, and how Clair is creating a wearable that tracks estrogen, progesterone, LH, and FSH continuously—all from the wrist.
In this episode, we explore:
- Why women’s health has historically been underserved in clinical research
- The future of personalized healthcare powered by wearables and AI
- How Clair organically grew to nearly 20,000 waitlist signups and 5,000 pre-orders before launch
Mentioned in this Episode:
Connect with Jenny & Clair Health: